Department of Surgery, St James's University Hospital, Leeds, United Kingdom.
Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, West Virginia, United States.
Am J Physiol Gastrointest Liver Physiol. 2024 Nov 1;327(5):G701-G710. doi: 10.1152/ajpgi.00057.2024. Epub 2024 Sep 3.
Mesenteric ischemia increases gut permeability and bacterial translocation. In human colon, chemical hypoxia induced by 2,4-dinitrophenol (DNP) activates basolateral intermediate conductance K (IK) channels (designated KCa3.1 or KCNN4) and increases paracellular shunt conductance/permeability (), but whether this leads to increased macromolecule permeability is unclear. Somatostatin (SOM) inhibits IK channels and prevents hypoxia-induced increases in . Thus, we examined whether octreotide (OCT), a synthetic SOM analog, prevents hypoxia-induced increases in human colon and hypoxia-induced increases in total epithelial conductance () and permeability to FITC-dextran 4000 (FITC) in rat colon. The effects of serosal SOM and OCT on increases in induced by 100 µM DNP were compared in isolated human colon. The effects of OCT on DNP-induced increases in and transepithelial FITC movement were evaluated in isolated rat distal colon. in DNP-treated human colon was 52% greater than in controls ( = 0.003). was similar when 2 µM SOM was added after or before DNP treatment, in both cases being less ( < 0.05) than with DNP alone. OCT (0.2 µM) was equally effective preventing hypoxia-induced increases in , whether added after or before DNP treatment. In rat distal colon, DNP significantly increased by 18% ( = 0.016) and mucosa-to-serosa FITC movement by 43% ( = 0.01), and 0.2 µM OCT pretreatment completely prevented these changes. We conclude that OCT prevents hypoxia-induced increases in paracellular/macromolecule permeability and speculate that it may limit ischemia-induced gut hyperpermeability during abdominal surgery, thereby reducing bacterial/bacterial toxin translocation and sepsis. Somatostatin (SOM, 2 µM) and octreotide (OCT, 0.2 µM, a long-acting synthetic analog of SOM) were equally effective in preventing chemical hypoxia-induced increases in paracellular shunt permeability/conductance in isolated human colon. In rat distal colon, chemical hypoxia significantly increased total epithelial conductance and transepithelial movement of FITC-dextran 4000, changes completely prevented by 0.2 µM OCT. OCT may prevent or limit gut ischemia during abdominal surgery, thereby decreasing the risk of bacterial/bacterial toxin translocation and sepsis.
肠系膜缺血会增加肠道通透性和细菌易位。在人类结肠中,2,4-二硝基苯酚(DNP)诱导的化学缺氧会激活基底外侧中间电导 K(IK)通道(称为 KCa3.1 或 KCNN4),并增加细胞旁短路通透性/电导(),但这是否会导致大分子通透性增加尚不清楚。生长抑素(SOM)抑制 IK 通道并防止缺氧诱导的增加。因此,我们研究了奥曲肽(OCT),一种合成的 SOM 类似物,是否可以防止缺氧诱导的人结肠增加,并防止缺氧诱导的大鼠结肠总上皮电导率()和 FITC-葡聚糖 4000(FITC)通透性增加。在分离的人结肠中比较了 100µM DNP 诱导时 SEROSAL SOM 和 OCT 对增加的影响。在分离的大鼠远端结肠中评估了 OCT 对 DNP 诱导的增加和跨上皮 FITC 运动的影响。在 DNP 处理的人结肠中增加了 52%(=0.003)。当在 DNP 处理后或之前添加 2µM SOM 时,是相似的,在两种情况下均小于(<0.05)与 DNP 单独处理。OCT(0.2µM)在添加 DNP 后或之前添加均可有效防止缺氧诱导的增加。在大鼠远端结肠中,DNP 显著增加了 18%(=0.016)和粘膜-浆膜 FITC 运动增加了 43%(=0.01),而 0.2µM OCT 预处理完全阻止了这些变化。我们得出结论,OCT 可防止缺氧诱导的细胞旁/大分子通透性增加,并推测其可能限制腹部手术期间的肠缺血性高通透性,从而减少细菌/细菌毒素易位和脓毒症。奥曲肽(SOM,2µM)和奥曲肽(OCT,0.2µM,SOM 的长效合成类似物)在防止化学缺氧诱导的人结肠细胞旁短路通透性/电导增加方面同样有效。在大鼠远端结肠中,化学缺氧显著增加了总上皮电导率和 FITC-葡聚糖 4000 的跨上皮运动,而 0.2µM OCT 则完全阻止了这些变化。OCT 可能会在腹部手术期间预防或限制肠道缺血,从而降低细菌/细菌毒素易位和脓毒症的风险。